mifobate has been researched along with thiazoles in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Desvergne, B; Escher, P; Michalik, L; Niesor, E; Rieusset, J; Touri, F; Wahli, W | 1 |
| Doggrell, S | 1 |
1 review(s) available for mifobate and thiazoles
| Article | Year |
|---|---|
Do peroxisome proliferation receptor-gamma antagonists have clinical potential as combined antiobesity and antidiabetic drugs?
Topics: Animals; Anti-Obesity Agents; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Organophosphorus Compounds; Receptors, Cytoplasmic and Nuclear; Thiazoles; Thiazolidinediones; Transcription Factors | 2003 |
1 other study(ies) available for mifobate and thiazoles
| Article | Year |
|---|---|
A new selective peroxisome proliferator-activated receptor gamma antagonist with antiobesity and antidiabetic activity.
Topics: 3T3 Cells; Adipocytes; Adipose Tissue; Adipose Tissue, Brown; Aged; Animals; Anti-Obesity Agents; Cell Differentiation; Epididymis; HeLa Cells; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Male; Mice; Mice, Knockout; Molecular Structure; Organophosphorus Compounds; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors | 2002 |